TENX - Tenax Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/20154/30/2015
Total Revenue---49.286
Cost of Revenue--9,727.3016,660.387
Gross Profit---9,727.301-6,611.101
Operating Expenses
Research Development3,527.31712,983.68112,983.68112,983.681
Selling General and Administrative5,678.5816,245.9585,910.9476,955.779
Non Recurring----
Others----
Total Operating Expenses9,205.89819,229.63915,638.24713,616.166
Operating Income or Loss-9,205.898-19,229.639-15,638.247-13,566.88
Income from Continuing Operations
Total Other Income/Expenses Net366.216-32,656.365536.3-514.932
Earnings Before Interest and Taxes-9,205.898-19,229.639-15,638.247-13,566.88
Interest Expense---2.261-49.081
Income Before Tax-8,839.682-51,886.004-15,101.946-14,081.812
Income Tax Expense--7,962.1--
Minority Interest----
Net Income From Continuing Ops-8,839.682-43,923.904-15,101.946-14,081.812
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,839.682-43,923.904-15,101.946-14,081.812
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,839.682-43,923.904-15,101.946-14,081.812